Protocol of insulin therapy for streptozotocin-diabetic rats based on a study of food ingestion and glycemic variation

Scandinavian Journal of Laboratory Animal Science

Volumn 38, Issue 2, 2011, Pages 117-127

  Pinheiro, Liliane Sena ^a   de Melo, Anderson Dutra ^a   Andreazzi, Ana Eliza ^b   de Caires Júnior, Luiz Carlos ^a   Costa, Mônica Barros ^a   Garcia, Raúl Marcel González ^a  

^a FEDERAL UNIVERSITY OF JUIZ DE FORA   (Brazil)

^b STATE UNIVERSITY OF MARINGÁ   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

FRUCTOSAMINE; GLUCOSE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; RECOMBINANT HUMAN INSULIN; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CLINICAL PROTOCOL; CONTROLLED STUDY; DIABETES MELLITUS; DRUG EFFICACY; FOOD INTAKE; FRUCTOSAMINE BLOOD LEVEL; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; MALE; NONHUMAN; RAT; STREPTOZOCIN DIABETES; TREATMENT RESPONSE; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT GAIN;

ANIMALIA; RATTUS; RATTUS NORVEGICUS;

EID: 84865639744     PISSN: 09013393     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. American Diabetes Association: Diagnosis and classification of diabetes mellitus. Diabetes Care 2008, 31, S55-S60.
2. Baker JR, PA Metcalf, RN Johnson, D Newman & P Rietz: Use of protein-based standards in automated colorimetric determinations of fructosamine in serum. Clin Chem. 1985, 31, 1550-1554.
3. Barceló A, C Aedo, S Rajpathak & S Robles: The cost of diabetes in Latin America and the Caribbean. Bull World Health Organ. 2003, 81,19-27
4. Bergmeyer HU & E Bernt: D-glucose: Determination with glucose oxidase and peroxidase. In: Bergmeyer HU (eds). Methods of Enzymatic Analysis. New York: Academic Press 1974, 1105-1212.
5. Bolzán AD & MS Bianchi: Genotoxicity of streptozotocin. Mutat Res. 2002, 512, 121-134.
6. Booth DA: Some characteristics of feeding during streptozotocin-induced diabetes in the rat. J Comp Physiol Psychol. 1972, 80, 238-249.
7. Castro JM & S Balagura: Meal patterning in the streptozotocin - diabetic rat. Physiol Behav. 1975, 15, 259-263.
8. Demaria-Pesce VH & S Nicolaidis: Mathematical determination of feeding patterns and Its consequence on correlational studies. Physiol Behav. 1998, 65, 157-170.
9. Ebara T, T Hirano, JCL Mamo, R Sakamaki, S Furukawa, S Nagano & T Takahashi: Hiperlipidemia in streptozotocin-diabetic hamster as a model for human insulin deficient diabetes: Comparasion to streptozotocin-diabetic rats. Metabolism. 1994, 43, 299-305.
10. Ferreira LDMC-B, D Xu, TN Palmer & PA Fournier: Effects of impaired glucose uptake on postexercise glycogen repletion in skeletal muscles of insulin-treaed streptozotocin-diabetic fasted rats. Metabolism. 2005, 54, 1420-1427.
11. Fossati P & L Prencipe: Serum triglycerides determined colorimetrically with an enzyme that produces hydrogen peroxide. Clin Chem. 1982, 28, 2077-2080.
12. Friedewald WT, RI Levy & DS Fredrickson: Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972, 18, 499-502.
13. Haughton CL, DL Dillehay & LS Phillips: Insulin replacement therapy for the rat model of streptozotocin-induced diabetes mellitus. Lab Anim Sci. 1999, 49, 639-644.
14. Inouye KE, JTY Yue, O Chan, T Kim, EM Akirav, E Park, MC Riddell, E Burdett, SG Matthews & M Vranic: Effects of insulin treatment without and with recurrent hypoglycemia on hypoglycemic counterregulation and adrenal catecholaminesynthesizing enzymes in diabetic rats. Endocrinology 2006, 147, 1860-1870.
15. Izbéki F, T Wittman, A Rosztóczy, N Linke, N Bódi, E Fekete & M Bagyanszki: Immediate insulin treatment prevents gut motility alterations and loss of nitrergic neurons in the ileum and colon of rats with streptozotocin-induced diabetes. Diabetes Res Clin Pract. 2008, 80, 192-198.
16. Kimberly MM, ET Leary, TG Cole & PP Waymack: Selection, validation, standardization, and performance of a designated comparison method for HDL-cholesterol for use in the cholesterol reference method laboratory network. Clin Chem. 1999, 45, 1803-1812.
17. Konrad RJ, I Mikolaenko, JF Tolar, K Liu & JE Kudlow: The potential mechanism of the diabetogenic action of streptozotocin: Inhibition of pancreatic ß-cell O-GlcNAC-selective Nacetyl-ß-D-glucosaminidase. The Biochem J. 2001, 356, 31-41.
18. Lenze S. The mechanisms of alloxan-and streptozotocin-induced diabetes. Diabetologia 2008, 51, 216-226.
19. Lim YS & MJ Staley: Measurement of plasma fructosamine evaluated for monitoring diabetes. Clin Chem. 1985, 31, 731-733
20. Liptakova A, J Carsky, O Ulicna, O Vancova, P Bozek & Z Durackova: Influence of ß-resorcylidene aminoguanidine on selected metabolic parameters and antioxidant status of rats with diabetes mellitus. Physiol Res. 2002, 51, 277-284.
21. Liu K, AJ Paterson, E Chin & JE Kudlow. Glucose stimulates protein modification by O linked GlcNAc in pancreatic ß cells: linkage of O linked GlcNAc to ß cell death. Proc Natl Acad Sci USA 2000, 97, 2820-2825.
22. Mahmud I, A Hossain, S Hossain, A Hannan, A Liaquat & M Hashimoto: Effect of Hilsa ilisa fish on the atherogenic lipid profile and glycaemic status of streptozotocin-treated type 1 diabetic rats. Clin Exp Pharmacol Physiol. 2004, 31, 76-81
23. Martin MB, BA Larsen, L Shea, D Hutchins & A Alfaro-Correa: State diabetes prevention and control program participation in the Health Disparities Collaborative: evaluating the first 5 years. Prev Chronic Dis. 2007, 4, 1-10.
24. Parra RS, LAF Mendes, R Fazan & HC Salgado: Pressure response to carotid occlusion in diabetic rats: effect of insulin therapy. Diabetes Res Clin Pract. 2005, 68, 12-17
25. Patel DG: Lack of glucagons response to hypoglycemia in long-term experimental diabetic rats. Diabetes 1983, 32, 55-60.
26. Pepato MT, EH Keller, AM Baviera, RC Kettelhut, RC Vendramini & IL Brunetti: Anti-diabetic activity of Bauhinia forficate decotion in streptozotocin-diabetic rats. J Ethnopharmacol. 2002, 81, 191-197.
27. Plaza AV, TG Granda & MTG Cachero: Circadian rhythms of food and water intake and urine excretion in diabetic rats. Physiol Behav. 1993, 54, 665-670.
28. Rastelli VMF, EH Akamine, MA Oliveira, D Nigro, RCT Passaglia, MHC Carvalho, ZB Fortes: Influence of insulin on the microvascular response to inflammatory mediators in neonatal streptozotocin diabetic rats. Inflamm Res. 2005, 54, 173-79.
29. Roglic G, N Unwin, PH Bennett, C Mathers, J Tuomilehto, S Nag, V Connolly & H King: The burden of mortality attributable to diabetes. Diabetes Care 2005, 28, 2130-2135.
30. Shima K, K Shi, Y Noma, C Yamamoto & K YSUKAWA: High-performance liquid chromatographic assay of rat serum glycated albumin. Diabetes 1991, 40(Supply1), 205A[Abstract].
31. Shimonura Y, M Takahashi, H Shimizu, N Sato, Y Uehara, M Negishi, T Inukai, I Kobayashi & S Kobayashi: Abnormal feeding behavior and insulin replacement in STZ-induced diabetic rats. Physiol Behav. 1990, 47, 731-734.
32. Soltani N, M Keshavarz & AR Dehpour. Effect of oral magnesium sulfate administration on blood pressure and lipide prolife in streptozotocin diabetic rat. Eur J Pharmacol. 2007, 560, 201-205.
33. Svensson L, P Elg, M Rasmussen, S Skrede, I Bjãrkhem: A possible model for accuracy control of determination of serum cholesterol with use of reference methods. A Nordkem project. Scan J Clin Lab Invest. 1982, 42, 99-105.
34. Szkudelski T: The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas. Physiol Res. 2001, 50, 536-546.
35. Taniguchi K, R Muroi, K Kobayashi-Hattori, Y Uda, Y Oishi & T Takita: Differing effects of watersoluble and fat-soluble extracts from Japanese radish (Raphanus sativus) sprouts on carbohydrate and lipid metabolism in normal and streptozotocin-induced diabetic-rats. J Nutr Sci Vitaminol. 2007, 53, 261-266.
36. Taniguchi Y, T Ooie, N Takahashi, T Shinohara, M Nakagawa, H Yonemochi, M Hara, H Yoshimatsu & T Saikawa: Pioglitazone but not glibenclamide improves cardiac expression of heat sock protein 72 and tolerance against ischemia/ reperfusion injury in the heredity insulin-resistant rat. Diabetes 2006, 55, 2371-2378.
37. Wild S, G Roglic, A Green, R Sicree & H King: Global prevalence of diabetes. Estimates for year 2000 and projections for 2030. Diabetes Care 2004, 27, 1047-1053.
38. Wilke RA & CJ Hillard: Decreased adrenal medullary catecholamine release in spontaneously diabetic BB-Wistar rats. Diabetes 1994, 43, 724-729.
39. Yono M, M Pouresmail, W Takahashi, JF Flanagan, RM Weiss & J Latifpour: Effect of insulin treatment on tissue size of the genitourinary tract in BB rats with spontaneously developed and streptozotocin-induced diabetes. Naunyn Schmiedebergs Arch Pharmacol. 2005, 372, 251-255.
40. Zagon IS, JW Sassani & PJ McLaughlin: Insulin treatment ameliorates inpaired corneal reepithelialization in diabetic rats. Diabetes 2006, 55, 1141-1147.